Photocatalytic Anticancer Activity of Cyclometalated Ir(III) Complexes: A Mechanistic Insight
Chemistry – An Asian Journal · 2025-11 · 20 (19)
DOI: 10.1002/asia.202500681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 21.07.2025. Verfasst von Ashish Kumar Yadav und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh, 221005, India. Hauptthemen laut MEDLINE: Iridium, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Banaras Hindu University, Board of Research in Nuclear Sciences.
Abstract (Originalsprache)
Three novel cyclometalated Ir(III) complexes, Ir1–Ir3 , were synthesized and thoroughly characterized. These complexes exhibited absorption in the 350–480 nm range, making them suitable candidates for visible‐light‐mediated photocatalytic cancer therapy. Under visible‐light exposure in a DMSO:PBS (1:99 v/v) solvent system, all three photocatalysts demonstrated high efficiency in facilitating NADH oxidation, attaining turnover frequencies (TOFs) in the range of 499–698 h⁻ 1 , exceeding the performance of most of the previously reported Ir(III)‐based photocatalysts. Mechanistic studies verified the involvement of type I and type II pathways for ROS generation. Cytotoxicity studies highlighted significant photocytotoxic effects of Ir1–Ir3 in human lung adenocarcinoma cells (A549), with Ir3 emerging as the most potent under light exposure. Additionally, the negligible dark and light cytotoxicity of Ir3 against human embryonic kidney cells (HEK‐293) demonstrated the safety profile of Ir3 . Furthermore, the mechanistic studies in A549 cells revealed that Ir3 promoted mitochondrial membrane depolarization and activated caspase‐3/7‐dependent apoptotic pathways through light‐triggered ROS generation and NADH oxidation. These findings highlight Ir3 as a potent dual‐action cancer phototherapeutic, capable of synergistically inducing type‐I and type‐II anticancer activity, and efficient NADH photo‐oxidation. This work presents a promising platform for developing multifunctional photocatalytic agents in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh, 221005, India.
- Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India.
- Radiation and Photochemistry Division, Bhabha Atomic Research Center, Anushaktinagar, Mumbai, 400085, India.
- Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.
Förderung
- Banaras Hindu University
- Board of Research in Nuclear Sciences
Zitieren
APA
Yadav, A. K., Singh, V., Singh, I., Kunwar, A., Koch, B., & Banerjee, S. (2025). Photocatalytic Anticancer Activity of Cyclometalated Ir(III) Complexes: A Mechanistic Insight. Chemistry – An Asian Journal, 20(19). https://doi.org/10.1002/asia.202500681
Vancouver
Yadav AK, Singh V, Singh I, Kunwar A, Koch B, Banerjee S. Photocatalytic Anticancer Activity of Cyclometalated Ir(III) Complexes: A Mechanistic Insight. Chemistry – An Asian Journal. 2025;20(19). doi:10.1002/asia.202500681
BibTeX
@article{Yadav2025,
author = {Yadav, Ashish Kumar and Singh, Virendra and Singh, Ishwar and Kunwar, Amit and Koch, Biplob and Banerjee, Samya},
title = {Photocatalytic Anticancer Activity of Cyclometalated Ir(III) Complexes: A Mechanistic Insight},
journal = {Chemistry – An Asian Journal},
year = {2025},
volume = {20},
number = {19},
doi = {10.1002/asia.202500681}
}
EUVIMED